10 articles tagged with "pharmaceuticals"
As the pharmaceutical industry evolves, Tim Cernak's shift from Big Pharma to nature-inspired drug design highlights a new approach to developing therapies with fewer side effects.
As the U.S. observes the situation, European countries are developing varied approaches to drug pricing, which could have significant implications for the pharmaceutical sector and patient access.
Recent reports highlight significant improvements in pancreatic cancer survival rates and ongoing developments in lung cancer drugs, alongside the rapid growth of China's biotech industry.
Telehealth prescribers are now under heightened scrutiny following FDA warnings about compounded weight loss drugs, while Lilly is actively opposing certain compounding practices.
The FDA has postponed its decision on AstraZeneca's experimental breast cancer pill after an advisory panel voted against its approval, signaling further review is needed.
Genentech is seeking research to bolster its position against potential pharmaceutical reforms in Washington, aiming to influence policy discussions.
The pharmaceutical giant Takeda Pharmaceuticals has agreed to a $13.6 million settlement concerning allegations of providing kickbacks to doctors for prescribing its antidepressant.
Varda Space Industries has entered a significant partnership with United Therapeutics to explore drug development in microgravity, marking a pivotal moment in the commercialization of space-based pharmaceuticals.
Pharmaceutical companies have ramped up their lobbying efforts, spending over $130 million in 2025, while Bristol-Myers Squibb has announced a new partnership with a Chinese firm.
The ANSM has imposed sanctions on Novo Nordisk and Eli Lilly for running promotional campaigns disguised as public awareness efforts, raising concerns about ethical advertising practices.